(Q38040822)

27 August 2017

Frontotemporal lobar degeneration: epidemiology, pathology, diagnosis and management (English)

1 reference

frontotemporal lobar degeneration

27 August 2017

0 references

1 reference

1 reference

Rachel E Seltman

1

1 reference

PubMed ID

22950490

27 August 2017

Brandy R Matthews

series ordinal

2

1 reference

27 August 2017

1 October 2012

1 reference

27 August 2017

30

1 reference

inferred from page(s)

published in

CNS Drugs

1 reference

27 August 2017

26

1 reference

27 August 2017

10

1 reference

27 August 2017

841-870

1 reference

https://scigraph.springernature.com/pub.10.2165/11640070-000000000-00000

27 August 2017

0 references

cites work

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Classification of primary progressive aphasia and its variants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

21 January 2018

Frontotemporal dementia

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Estimating the number of persons with frontotemporal lobar degeneration in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia: patient characteristics, cognition, and behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Survival in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Update on frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The prevalence of frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

New insights into biological markers of frontotemporal lobar degeneration spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia progresses to death faster than Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Survival in Alzheimer disease: a multiethnic, population-based study of incident cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Determinants of survival in behavioral variant frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Executive function in progressive and nonprogressive behavioral variant frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Familial aggregation in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal lobar degeneration: demographic characteristics of 353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Semantic dementia versus nonfluent progressive aphasia: neuropsychological characterization and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Behaviour in frontotemporal dementia, Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Episodic memory in frontotemporal dementia: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Different patterns of magnetic resonance imaging atrophy for frontotemporal lobar degeneration syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Patterns of brain atrophy in frontotemporal dementia and semantic dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Magnetoencephalography of frontotemporal dementia: spatiotemporally localized changes during semantic decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Amyloid vs FDG-PET in the differential diagnosis of AD and FTLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neuroanatomical correlates of behavioural disorders in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Structural anatomy of empathy in neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neuroanatomical correlates of impaired recognition of emotion in dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Eating and hypothalamus changes in behavioral-variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Predicting functional decline in behavioural variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Connected speech production in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cognition and anatomy in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Slowly progressive aphasia without generalized dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The logopenic/phonological variant of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Language comprehension and regional cerebral defects in frontotemporal degeneration and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Focal cortical presentations of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical and pathological characterization of progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cortical basal ganglionic degeneration presenting with "progressive loss of speech output and orofacial dyspraxia"

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Prediction of pathology in primary progressive language and speech disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Progressive loss of speech: a neuropsychological profile of premotor dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Apraxia of speech and nonfluent aphasia: a new clinical marker for corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Prevalence and natural history of progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Epidemiology of progressive supranuclear palsy. ESGAP Consortium. European Study Group on Atypical Parkinsonisms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neuropathological background of phenotypical variability in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The multiple phenotypes of corticobasal syndrome and corticobasal degeneration: implications for further study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Early frontotemporal dementia targets neurons unique to apes and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau mutations in frontotemporal dementia FTDP-17 and their relevance for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Analysis of tau haplotypes in Pick's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau pathology and future therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A harmonized classification system for FTLD-TDP pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Caudate atrophy on MRI is a characteristic feature of FTLD-FUS

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Phenotypic signatures of genetic frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neuroimaging signatures of frontotemporal dementia genetics: C9ORF72, tau, progranulin and sporadics

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Distinct genetic forms of frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau is a candidate gene for chromosome 17 frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The role of tau (MAPT) in frontotemporal dementia and related tauopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L)

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Dementia and neurodevelopmental predisposition: cognitive dysfunction in presymptomatic subjects precedes dementia by decades in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The heritability and genetics of frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Granulins, a novel class of peptide from leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Roles of progranulin in sexual differentiation of the developing brain and adult neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Accelerated lipofuscinosis and ubiquitination in granulin knockout mice suggest a role for progranulin in successful aging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Genetics of familial and sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Are amyotrophic lateral sclerosis patients cognitively normal?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cognitive impairment, frontotemporal dementia, and the motor neuron diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Dementia and cognitive impairment in amyotrophic lateral sclerosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cognitive impairment in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Familial frontotemporal dementia with amyotrophic lateral sclerosis and a shared haplotype on chromosome 9p

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The overlap of amyotrophic lateral sclerosis and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Predicting survival in frontotemporal dementia with motor neuron disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Sense and sensitivity of novel criteria for frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Biomarkers in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cerebrospinal fluid biomarkers in the differential diagnosis of Alzheimer's disease from other cortical dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Increased tau in the cerebrospinal fluid of patients with frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Serum biomarker for progranulin-associated frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Plasma progranulin levels predict progranulin mutation status in frontotemporal dementia patients and asymptomatic family members

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Neurodegenerative diseases target large-scale human brain networks

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Off-label medication use in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

21 January 2018

Frontotemporal Dementia

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia: a randomised, controlled trial with trazodone

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Rivastigmine in frontotemporal dementia: an open-label study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Galantamine in frontotemporal dementia and primary progressive aphasia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Memantine for behavioral disturbances in frontotemporal dementia: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A 6-month, open-label study of memantine in patients with frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

An open-label study of memantine treatment in 3 subtypes of frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Longitudinal tracking of FTLD: toward developing clinical trial methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Aging and Alzheimer's disease. Altered cortical serotonergic binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Altered serotonergic and cholinergic synaptic markers in Pick's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Imbalance of a serotonergic system in frontotemporal dementia: implication for pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Widespread origin of the primate mesofrontal dopamine system.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Oxytocin increases trust in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Face and emotion processing in frontal variant frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Impaired recognition of negative facial emotions in patients with frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

The effects of oxytocin on social cognition and behaviour in frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Effect of ferulic acid and Angelica archangelica extract on behavioral and psychological symptoms of dementia in frontotemporal lobar degeneration and dementia with Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A model for management of behavioral symptoms in frontotemporal lobar degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Responding to safety issues in frontotemporal dementias

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Physical exercise as a preventive or disease-modifying treatment of dementia and brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Caregiver burden, health-related quality of life and coping in dementia caregivers: a comparison of frontotemporal dementia and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Zarit burden inventory and activities of daily living in the behavioral variant of frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Tau Protein in Cerebrospinal Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Apraxia of speech in degenerative neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11640070-000000000-00000

Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors

21 January 2018

1 reference

12 December 2020

Pick's disease: a modern approach.

1 reference

12 December 2020

Tau protein in cerebrospinal fluid: a new diagnostic and prognostic marker in Alzheimer disease?

1 reference

12 December 2020

Progranulin gene expression regulates epithelial cell growth and promotes tumor growth in vivo

1 reference

12 December 2020

Progressive apraxia of speech as a sign of motor neuron disease

1 reference

12 December 2020

Vulnerability to neuroleptic side effects in frontotemporal dementia

1 reference

12 December 2020

Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor).

1 reference

12 December 2020

Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly

1 reference

12 December 2020

Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method

1 reference

12 December 2020

Factors underlying caregiver stress in frontotemporal dementia and Alzheimer's disease

1 reference

12 December 2020

Neurochemical and histopathologic alterations characteristic of Pick's disease in a non-demented individual.

1 reference

12 December 2020

FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation

1 reference

12 December 2020

Primary progressive aphasia

1 reference

12 December 2020

Frontotemporal dementia: a review for primary care physicians.

1 reference

12 December 2020

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

1 reference

12 December 2020

Memantine in behavioral variant frontotemporal dementia: negative results.

1 reference

12 December 2020

Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone

1 reference

12 December 2020

Widespread cytoskeletal pathology characterizes corticobasal degeneration

1 reference

12 December 2020

Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology

1 reference

12 December 2020

Progranulin null mutations in both sporadic and familial frontotemporal dementia

1 reference

12 December 2020

Advanced practice nursing: meeting the caregiving challenges for families of persons with frontotemporal dementia

1 reference

12 December 2020

Cerebral glucose metabolism in patients with frontotemporal dementia.

1 reference

12 December 2020

The epidemiology of PSP

1 reference

12 December 2020

Progranulin: normal function and role in neurodegeneration

1 reference

12 December 2020

Purification of an autocrine growth factor homologous with mouse epithelin precursor from a highly tumorigenic cell line

1 reference

12 December 2020

Frontal degenerative dementia and neuroimaging.

1 reference

12 December 2020

Perception of emotion in frontotemporal dementia and Alzheimer disease.

1 reference

12 December 2020

Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype

1 reference

12 December 2020

Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD.

1 reference

12 December 2020

The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994

1 reference

12 December 2020

10.2165/11640070-000000000-00000

Identifiers

DOI

1 reference

PubMed ID

22950490

Dimensions Publication ID

27 August 2017

0 references

1 reference

PubMed ID

22950490